封面
市场调查报告书
商品编码
1577076

女性健康设备市场、机会、成长动力、产业趋势分析与预测,2024-2032

Women Health Devices Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 199 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球女性健康器材市场价值约为1,299亿美元,预计2024年至2032年复合年增长率为9.2%。状况。这些设备满足女性从青春期到更年期等各个生命阶段的解剖和生理需求。它们涵盖生殖健康、妇科护理以及乳癌、子宫颈癌、骨质疏鬆症和骨盆底疾病等疾病。全球人口老化,尤其是女性人口老化,导致尿失禁问题日益严重。这种情况通常是由于骨盆底肌肉衰弱造成的,影响着美国约 2500 万成年人,其中 75-80% 是女性,全世界约有 2 亿人受到这种情况的影响。

整个女性健康器械产业根据产品、应用、最终用户和地区进行分类。

女性健康器械市场分为器械和消耗品。设备领域包括避孕设备、生育监测工具、经期保健产品、乳房及骨盆腔健康设备、孕产妇保健产品、一般健康监测仪、妇科医疗设备等。预测显示,到2032 年,这一领域将达到2,114 亿美元。 ,以及社会向预防性医疗保健的转变。

市场分为癌症、骨质疏鬆、传染病、子宫肌瘤、怀孕、女性绝育、月经失调等领域。在分析期间,传染病细分市场的复合年增长率预计为 7.9%。影响女性的传染病,如泌尿道感染 (UTI)、性传染感染 (STI) 和阴道感染,在全球范围内普遍流行。例如,世界卫生组织在 2022 年报告称,有 2,000 万名女性爱滋病毒呈阳性,新增病例 54 万例,相关死亡人数为 2.3 万人。

在美国,到 2032 年,女性健康设备市场预计将达到 788 亿美元。促进定期筛检和早期诊断(尤其是乳癌和骨质疏鬆症)的措施进一步推动了这一成长。其他成长动力包括医疗保健支出的增加、政府的支持性倡议、医疗技术的进步以及与生活方式相关的疾病的日益流行。这些因素共同提高了女性医疗保健的可近性和质量,从而扩大了市场。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业影响力
    • 成长动力
      • 已开发国家妇女的​​疾病负担日益增加
      • 全球老年女性人口不断增加
      • 医疗保健产业的技术进步
      • 提高发展中国家对妇女健康的认识
    • 产业陷阱与挑战
      • 设备和程序成本高
      • 欠发达经济体的妇女缺乏认识
  • 成长潜力分析
  • 技术景观
  • 未来市场趋势
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:按产品分类,2021 - 2032 年

  • 主要趋势
  • 装置
    • 避孕器具
    • 生育力监测设备
    • 经期保健品
    • 乳房健康装置
    • 骨盆健康设备
    • 孕产妇保健品
    • 一般健康监测设备
    • 用于妇科疾病的医疗器械
    • 其他设备
  • 耗材

第 6 章:市场估计与预测:按应用分类,2021 - 2032

  • 主要趋势
  • 癌症
  • 骨质疏鬆症
  • 传染病
  • 子宫肌瘤
  • 怀孕
  • 女性绝育
  • 月经失调
  • 其他应用

第 7 章:市场估计与预测:按最终用户划分,2021 - 2032 年

  • 主要趋势
  • 医院
  • 妇产科诊所
  • 诊断实验室
  • 门诊手术中心
  • 其他最终用户

第 8 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 丹麦
    • 瑞典
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 卡达
    • 中东和非洲其他地区

第 9 章:公司简介

  • Abbott Laboratories
  • Allengers Medical
  • Alphabet Inc.
  • Caldera Medical
  • Carestream Health
  • Garmin Ltd.
  • GE Healthcare Technologies Inc.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Mankind Pharma Limited
  • OMRON Corporation
  • Organon and Co.
  • Samsung Electronics co., Ltd.
  • The Cooper Companies, Inc.
简介目录
Product Code: 3191

The Global Women Health Devices Market was valued at approximately USD 129.9 billion in 2023 and is projected to grow at a CAGR of 9.2% from 2024 to 2032. Women's health devices include medical instruments, equipment, and tools designed for diagnosing, monitoring, and treating health conditions unique to women. These devices address the anatomical and physiological needs of women throughout various life stages, from adolescence to menopause and beyond. They cover reproductive health, gynecological care, and conditions like breast cancer, cervical cancer, osteoporosis, and pelvic floor disorders. The aging global population, particularly among women, is increasing urinary incontinence issues. This condition, often due to weakened pelvic floor muscles, affects about 25 million adults in the U.S., with 75-80% being women, and around 200 million worldwide.

The overall women health devices industry is classified based on the product, application, end use r, and region.

The women health devices market is divided into devices and consumables. The devices segment includes contraceptive devices, fertility monitoring tools, menstrual health products, breast and pelvic health devices, maternal health products, general health monitors, gynecological medical devices, and more. Forecasts suggest this segment will reach USD 211.4 billion by 2032. Several factors drive this growth: heightened awareness among women about their health needs, the emergence of specialized devices, technological advancements yielding efficient and user-friendly products, and a societal shift towards preventive healthcare.

The market is divided into areas like cancer, osteoporosis, infectious diseases, uterine fibroids, pregnancy, female sterilization, and menstrual disorders. The infectious diseases segment is set to grow at a CAGR of 7.9% during the analysis period. Infectious diseases affecting women, such as urinary tract infections (UTIs), sexually transmitted infections (STIs), and vaginal infections, are globally prevalent. For instance, the WHO reported in 2022 that twenty million women were HIV-positive, with 540,000 new cases and 23,000 related deaths.

In the U.S., the women health devices market is projected to reach USD 78.8 billion by 2032. Heightened awareness about women's health and preventive care drives the demand for specialized devices. Initiatives promoting regular screenings and early diagnoses, especially for breast cancer and osteoporosis, further fuel this growth. Other growth drivers include rising healthcare expenditures, supportive government initiatives, medical technology advancements, and the increasing prevalence of lifestyle-related diseases. Together, these factors enhance women's healthcare accessibility and quality, expanding the market.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry impact forces
    • 3.1.1 Growth drivers
      • 3.1.1.1 Increasing disease burden among women in developed countries
      • 3.1.1.2 Rising elderly female population worldwide
      • 3.1.1.3 Technological advancements in healthcare industry
      • 3.1.1.4 Increasing awareness regarding women health in developing countries
    • 3.1.2 Industry pitfalls and challenges
      • 3.1.2.1 High cost of devices and procedures
      • 3.1.2.2 Lack of awareness among women in underdeveloped economies
  • 3.2 Growth potential analysis
  • 3.3 Technology landscape
  • 3.4 Future market trends
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Devices
    • 5.2.1 Contraceptive devices
    • 5.2.2 Fertility monitoring devices
    • 5.2.3 Menstrual health products
    • 5.2.4 Breast health devices
    • 5.2.5 Pelvic health devices
    • 5.2.6 Maternal health products
    • 5.2.7 General health monitoring devices
    • 5.2.8 Medical devices for gynecological conditions
    • 5.2.9 Other devices
  • 5.3 Consumables

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cancer
  • 6.3 Osteoporosis
  • 6.4 Infectious diseases
  • 6.5 Uterine fibroids
  • 6.6 Pregnancy
  • 6.7 Female sterilization
  • 6.8 Menstrual disorders
  • 6.9 Other applications

Chapter 7 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Obstetrics and gynecology clinics
  • 7.4 Diagnostic laboratories
  • 7.5 Ambulatory surgical centers
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
    • 8.3.7 Denmark
    • 8.3.8 Sweden
    • 8.3.9 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Qatar
    • 8.6.5 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Allengers Medical
  • 9.3 Alphabet Inc.
  • 9.4 Caldera Medical
  • 9.5 Carestream Health
  • 9.6 Garmin Ltd.
  • 9.7 GE Healthcare Technologies Inc.
  • 9.8 Hologic, Inc.
  • 9.9 Koninklijke Philips N.V.
  • 9.10 Mankind Pharma Limited
  • 9.11 OMRON Corporation
  • 9.12 Organon and Co.
  • 9.13 Samsung Electronics co., Ltd.
  • 9.14 The Cooper Companies, Inc.